This Best Practices Report intends to bring our experience in European Industrial Doctorates (EID) to other consortia with awarded EID Programmes ongoing and to institutions considering applying for funding to this scheme.
The fellows will move to GSK's Tres Cantos site in Spain for the second stage of the project.
The fellows presented their first year scientific results at the GSK DDW site
OpenMedChem selected three Early Stage Researchers: Olga Balabon form Ukraine, Eleni Pitta from Greece and Maciej Rogacki from Poland. They were chosen out of more than 150 candidates.
OpenMedChem was launched officially at January 1st, 2013. Find out more about our research goals...
OpenMedChem unites Industrial and Academic research effort and receives funding from the FP7 program of the European Commission.
Join the Orchid Neglected Diseases Drug Development Community!